Heart Coherence Training on Vascular Ehlers-Danlos Syndrome Patients

Plain-language summary

This study examines the effects of heart coherence (HeartMath) training in patients with vascular Ehlers-Danlos syndrome confirmed by a mutation in the COL3A1 gene. It enrolls English-speaking patients aged 12 to 45 who have access to a smartphone and the internet. It is a study with no assigned phase and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Recruiting

Sponsor

Baylor College of Medicine

Intervention

Heartmath Intervention, Control Group

Start date

4/1/2024

Estimated completion

1/1/2028

Countries

United States

Related genes

Locations

• Houston, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Participants must be diagnosed with Vascular Ehlers-Danlos Syndrome verified by a mutation of the COL3A1 gene
* Ages 12-45 year at the time of enrollment
* Access to a smartphone as well as an additional device with camera and microphone
* Stable internet access
* English speaking

Exclusion Criteria:

* Non-English speakers
* Any conditions or developmental delays limiting the ability to utilize technology or follow directions.